{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:57:36Z","timestamp":1795021056969,"version":"4.10.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Gilead Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-57284-w","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:04:50Z","timestamp":1741064690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7277-9314","authenticated-orcid":false,"given":"Lucia","family":"Bail\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Molt\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julen","family":"Cadi\u00f1anos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Carlos Lopez Bernaldo de Quir\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"de Los Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ambrosioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkaitz","family":"Imaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Benet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6871-0098","authenticated-orcid":false,"given":"Paula","family":"Suanzes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7187-0367","authenticated-orcid":false,"given":"Jordi","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Busca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leire","family":"P\u00e9rez-Latorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8541-8200","authenticated-orcid":false,"given":"Juan","family":"Berenguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio Jes\u00fas","family":"Garc\u00eda-Fraile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Mej\u00eda-Abril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Sc\u00e9vola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1138-5770","authenticated-orcid":false,"given":"Pere","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Frankot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daina","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5595-1773","authenticated-orcid":false,"given":"Elena","family":"Vendrame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Wallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romas","family":"Geleziunas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devi","family":"SenGupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9977-8634","authenticated-orcid":false,"given":"Yovaninna","family":"Alarc\u00f3n-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Aranguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6470-8476","authenticated-orcid":false,"given":"Ian","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-5778","authenticated-orcid":false,"given":"Christian","family":"Brander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ram\u00f3n","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9975-407X","authenticated-orcid":false,"given":"Beatriz","family":"Mothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the AELIX-003 Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"de Los Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Cobars\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroa","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samandhy","family":"Cede\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonaventura","family":"Clotet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulalia","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuska","family":"Llano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Lui\u0301s","family":"Cabero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Naval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicen\u00e7","family":"Falc\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibiana","family":"Planas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Buz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell","family":"Genesc\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Borobia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Honta\u00f1on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Queiruga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Mican","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Seco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Diez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Gij\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Mart\u00edn-V\u00edlchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"de Miguel-C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"De la Torre-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Ariza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benito","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Morenilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Niub\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Piatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"57284_CR1","doi-asserted-by":"publisher","first-page":"S812","DOI":"10.1093\/infdis\/jix403","volume":"216","author":"T Minior","year":"2017","unstructured":"Minior, T. et al. The critical role of supply chains in preventing human immunodeficiency virus drug resistance in low- and middle-income settings. J. Infect. Dis. 216, S812\u2013S815 (2017).","journal-title":"J. Infect. Dis."},{"key":"57284_CR2","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s41591-021-01590-5","volume":"27","author":"SG Deeks","year":"2021","unstructured":"Deeks, S. G. et al. Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021. Nat. Med. 27, 2085\u20132098 (2021).","journal-title":"Nat. Med."},{"key":"57284_CR3","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1038\/s41591-022-02060-2","volume":"28","author":"L Bail\u00f3n","year":"2022","unstructured":"Bail\u00f3n, L. et al. Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial. Nat. Med. 28, 2611\u20132621 (2022).","journal-title":"Nat. Med."},{"key":"57284_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.eclinm.2019.05.009","volume":"11","author":"B Mothe","year":"2019","unstructured":"Mothe, B. et al. Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study). EClinicalMedicine 11, 65\u201380 (2019).","journal-title":"EClinicalMedicine"},{"key":"57284_CR5","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/S0140-6736(19)32990-3","volume":"395","author":"S Fidler","year":"2020","unstructured":"Fidler, S. et al. Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial. Lancet 395, 888\u2013898 (2020).","journal-title":"Lancet"},{"key":"57284_CR6","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3389\/fimmu.2020.00418","volume":"11","author":"M Ros\u00e1s-Umbert","year":"2020","unstructured":"Ros\u00e1s-Umbert, M. et al. In vivo effects of romidepsin on T-cell activation, apoptosis and function in the BCN02 HIV-1 Kick&Kill Clinical Trial. Front. Immunol. 11, 418 (2020).","journal-title":"Front. Immunol."},{"key":"57284_CR7","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1016\/S2352-3018(16)30055-8","volume":"3","author":"S Leth","year":"2016","unstructured":"Leth, S. et al. Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B\/2A trial. Lancet HIV 3, e463\u2013472 (2016).","journal-title":"Lancet HIV"},{"key":"57284_CR8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.immuni.2012.01.014","volume":"36","author":"L Shan","year":"2012","unstructured":"Shan, L. et al. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 36, 491\u2013501 (2012).","journal-title":"Immunity"},{"key":"57284_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-017-0387-9","volume":"15","author":"C Deleage","year":"2018","unstructured":"Deleage, C., Chan, C. N., Busman-Sahay, K. & Estes, J. D. Next-generation in situ hybridization approaches to define and quantify HIV and SIV reservoirs in tissue microenvironments. Retrovirology 15, 4 (2018).","journal-title":"Retrovirology"},{"key":"57284_CR10","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.3389\/fimmu.2019.01842","volume":"10","author":"SH Huang","year":"2019","unstructured":"Huang, S. H. et al. Have cells harboring the HIV reservoir been immunoedited? Front. Immunol. 10, 1842 (2019).","journal-title":"Front. Immunol."},{"key":"57284_CR11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41586-018-0600-6","volume":"563","author":"EN Borducchi","year":"2018","unstructured":"Borducchi, E. N. et al. Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys. Nature 563, 360\u2013364 (2018).","journal-title":"Nature"},{"key":"57284_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31196-5","volume":"13","author":"VEK Walker-Sperling","year":"2022","unstructured":"Walker-Sperling, V. E. K. et al. Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques. Nat. Commun. 13, 3463 (2022).","journal-title":"Nat. Commun."},{"key":"57284_CR13","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nature20583","volume":"540","author":"EN Borducchi","year":"2016","unstructured":"Borducchi, E. N. et al. Ad26\/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys. Nature 540, 284\u2013287 (2016).","journal-title":"Nature"},{"key":"57284_CR14","doi-asserted-by":"crossref","unstructured":"SenGupta, D. et al. The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy. Sci. Transl. Med. 13, eabg3071 (2021).","DOI":"10.1126\/scitranslmed.abg3071"},{"key":"57284_CR15","doi-asserted-by":"publisher","first-page":"e815","DOI":"10.1093\/cid\/ciaa1534","volume":"72","author":"SA Riddler","year":"2021","unstructured":"Riddler, S. A. et al. Vesatolimod, a toll-like receptor 7 agonist, induces immune activation in virally suppressed adults living with human immunodeficiency virus-1. Clin. Infect. Dis. 72, e815\u2013e824 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"57284_CR16","doi-asserted-by":"crossref","unstructured":"Bam, R. A. et al. TLR7 agonist GS-9620 is a potent inhibitor of acute HIV-1 infection in human peripheral blood mononuclear cells. Antimicrob. Agents Chemother. 61, e01369-16 (2016).","DOI":"10.1128\/AAC.01369-16"},{"key":"57284_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.immuni.2012.09.005","volume":"37","author":"PJ Goulder","year":"2012","unstructured":"Goulder, P. J. & Walker, B. D. HIV and HLA class I: an evolving relationship. Immunity 37, 426\u2013440 (2012).","journal-title":"Immunity"},{"key":"57284_CR18","first-page":"2258","volume":"75","author":"\u00c1 Bay\u00f3n-Gil","year":"2020","unstructured":"Bay\u00f3n-Gil, \u00c1. et al. HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial design. J. Antimicrob. Chemother. 75, 2258\u20132263 (2020).","journal-title":"J. Antimicrob. Chemother."},{"key":"57284_CR19","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s40121-024-01034-w","volume":"13","author":"SA Riddler","year":"2024","unstructured":"Riddler, S. A. et al. A pooled analysis of eight clinical studies suggests a link between influenza-like symptoms and pharmacodynamics of the toll-like receptor-7 agonist vesatolimod. Infect. Dis. Ther. 13, 2285\u20132299 (2024).","journal-title":"Infect. Dis. Ther."},{"key":"57284_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/COH.0000000000000118","volume":"10","author":"R Rajasuriar","year":"2015","unstructured":"Rajasuriar, R., Wright, E. & Lewin, S. R. Impact of antiretroviral therapy (ART) timing on chronic immune activation\/inflammation and end-organ damage. Curr. Opin. HIV AIDS 10, 35\u201342 (2015).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"57284_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104253","volume":"84","author":"H Takata","year":"2022","unstructured":"Takata, H. et al. Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8(+) T cells. EBioMedicine 84, 104253 (2022).","journal-title":"EBioMedicine"},{"key":"57284_CR22","unstructured":"ClinicalTrials.gov. NCT05281510. https:\/\/www.clinicaltrials.gov\/study\/NCT05281510."},{"key":"57284_CR23","unstructured":"ClinicalTrials.gov. NCT06071767. https:\/\/www.clinicaltrials.gov\/study\/NCT06071767."},{"key":"57284_CR24","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1038\/s41591-022-02023-7","volume":"28","author":"JD Gunst","year":"2022","unstructured":"Gunst, J. D. et al. Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b\/2a, randomized trial. Nat. Med. 28, 2424\u20132435 (2022).","journal-title":"Nat. Med."},{"key":"57284_CR25","unstructured":"ClinicalTrials.gov. NCT05208125. https:\/\/www.clinicaltrials.gov\/study\/NCT05208125."},{"key":"57284_CR26","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1097\/00002030-200309050-00005","volume":"17","author":"EW Fiebig","year":"2003","unstructured":"Fiebig, E. W. et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17, 1871\u20131879 (2003).","journal-title":"AIDS"},{"key":"57284_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-9-208","volume":"9","author":"B Mothe","year":"2011","unstructured":"Mothe, B. et al. Definition of the viral targets of protective HIV-1-specific T cell responses. J. Transl. Med. 9, 208 (2011).","journal-title":"J. Transl. Med."},{"key":"57284_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0392-5","volume":"13","author":"B Mothe","year":"2015","unstructured":"Mothe, B. et al. A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques. J. Transl. Med. 13, 60 (2015).","journal-title":"J. Transl. Med."},{"key":"57284_CR29","doi-asserted-by":"publisher","first-page":"e40385","DOI":"10.1371\/journal.pone.0040385","volume":"7","author":"MD Dicks","year":"2012","unstructured":"Dicks, M. D. et al. A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity. PLoS ONE 7, e40385 (2012).","journal-title":"PLoS ONE"},{"key":"57284_CR30","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1371\/journal.pone.0000984","volume":"2","author":"S L\u00e9tourneau","year":"2007","unstructured":"L\u00e9tourneau, S. et al. Design and pre-clinical evaluation of a universal HIV-1 vaccine. PLoS ONE 2, e984 (2007).","journal-title":"PLoS ONE"},{"key":"57284_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-019-0898-8","volume":"566","author":"KM Bruner","year":"2019","unstructured":"Bruner, K. M. et al. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses. Nature 566, 120\u2013125 (2019).","journal-title":"Nature"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57284-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57284-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57284-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:04:54Z","timestamp":1741064694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57284-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57284"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57284-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.Brander and B.M. are co-inventors of the HTI immunogen (patent application PCT\/EP2013\/051596). C.Brander, B.M., and I.M. are co-inventors of US patent Application No. 62\/935,519 and US Appl. No. 62\/851,546, which have relevance to the vaccine regimen used in this study. B.M. reports consultancy, advisory, and\/or speaker fees from AELIX Therapeutics, Gilead Sciences, Janssen, ViiV, and MSD. J.M. reports advisory board and speaker fees and grant support from MSD, AbbVie, Boehringer Ingelheim, Gilead Sciences, ViiV Healthcare, Janssen-Cilag, and Bristol Myers Squibb. A.C. reports advisory and speaker fees and grant support from Gilead Sciences, Janssen, MSD, and ViiV Healthcare. P.S. reports advisory and\/or speaker fees and\/or support for attending meetings from Gilead Sciences, Janssen-Cilag, Merck Sharp & Dohme, Pfizer, and ViiV Healthcare, and has received a research grant from ViiV Healthcare, all outside of the submitted work. J.B. reports speaker fees and grant support from Gilead Sciences and MSD. J.C. reports speaker fees and grant support from Gilead Sciences and MSD. J.A. reports advisory board and speaker fees and grant support from Gilead Sciences, Janssen, MSD, ViiV; data and safety monitoring board membership with Grifols and HIPRA; and is an employee of the European AIDS Clinical Society (guidelines coordinator). A.I. reports advisory and speaker fees and grant support from Gilead Sciences, Janssen, MSD, Theratechnologies, and ViiV. S.M. reports speaking fees and research grants from Gilead Sciences, Janssen-Cilag, MSD, and ViiV. P.D. reports lecture and advisory board fees from ViiV Healthcare, MSD, GSK, Roche, Theratechnologies, Janssen & Cilag, and Gilead. Y.C., Y.T., R.G., D.S., D.L. J.J.W., S.G., and E.V. are employees and stockholders of Gilead Sciences, Inc. M.F. is an employee of ClinData Insight Inc, whose services were funded by Gilead Sciences, Inc. I.M. was an employee of AELIX Therapeutics, is currently an employee of Orion Biotechnology and is a consultant for Synklino. M.G.G. was an employee of AELIX Therapeutics at the time the research was conducted. J.M.M. has received consulting honoraria and\/or research grants from Angelini, Contrafect, Cubist, Genentech, Gilead Sciences, Jansen, Lysovant, Medtronic, MSD, Novartis, Pfizer, and ViiV Healthcare, outside the submitted work. J.N. has received honoraria and\/or speaking fees and\/or financial support for attending conferences from AbbVie, Gilead Sciences, Janssen-Cilag, Merck Sharp & Dome, and ViiV Healthcare outside of the submitted work. C.Brander is the cofounder, shareholder, and CSO of AELIX. J.R.A. reports advisory and speaker fees and grant support from ViiV, Janssen, Gilead Sciences, MSD, and AELIX Therapeutics. The remaining authors declare that the research was conducted in the absence of any conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2146"}}